Proposition - PharmXpert Academy

330 2007 Korea Pharmaceutical Industry Directory
Since the establishment, the central laboratory has been expanding its area of
research for new drug invention based on the laboratory’s intensive R&D efforts
and superior pharmaceutics professionals.
Concentration of investment for the invention of new drugs has enabled us to
develop products such as the hypertension medicine ‘Captopril’, the anti-cancer
medicine ‘Doxorubicin’ produced from the nation’s largest fermentation facility and
oral and injection typhoid vaccine. In 2002, we acquired COS certification from
Europe for the materials of doxorubicin which helped in accelerating the
company’s international exportation
Product Effects Process Plan for 2007
Fimasartan
For hypertension
FLUGEL Antibacteria agent for external use
OFD
Intraoral soluble pill(For
hepertension)
Completed early clinical 2 phage
test, toxicity of Dog 52 week,
oncogenicity and ADME test
Completed medicine research and
clinical 3 phage test
Completed research on medicine
Epirubicin Anticancer Completed new product -
TSS Treatment for prostatism Completed new product -
Test for later clinical 2 phage,
oncogenicity, ADME test and majo
matabolite
On sale
Developing new product
AST+SVT For hyperlipemia Research on medicine Clinical and efficacy test
PISP
Manufacturing high-value protein
for medicinal use using plant cells
Processing joint research with a
team of InHa Univ.
Processing the National Task of the
Ministry of Commerce, Industry
and Energy
DNP For dementia Research on medicine Developing new product
TPM
CLP
Anti-convulsant
For circulation
Research on combination and
medicine
Research on combination and
medicine
Developing new product
Developing new product